Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation "XANTUS"


Phase N/A Results N/A

Summary of Purpose

This is an international observational study in patients with non-valvular atrial fibrillation who are prescribed rivaroxaban under routine treatment conditions to prevent stroke or non-central nervous system systemic embolism.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 July 2016.

1 Jun 2012 24 May 2012 1 Mar 2015 1 Mar 2015 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample